Finance

Beta
Lists
LRMR:NASDAQ
Larimar Therapeutics Inc
$3.63
-1.36%
(-0.050) 1D
$3.67
+1.10% (+0.040)
After hours
Closed: Jun 24, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for LRMR...
Open
$3.69
High
$3.80
Low
$3.61
Mkt. cap
377.09M
Avg. vol.
1.94M
Volume
1.57M
52-wk high
$6.42
52-wk low
$2.72
EPS
-$2.08
Beta
0.83
Shares outstanding
103.88M
No. of employees
71
Open
$3.69
High
$3.80
Low
$3.61
Mkt. cap
377.09M
Avg. vol.
1.94M
Volume
1.57M
52-wk high
$6.42
52-wk low
$2.72
EPS
-$2.08
Beta
0.83
Shares outstanding
103.88M
No. of employees
71
News stories
From sources across the web
About Larimar Therapeutics Inc
CEO-
Employees71
Founded2005
HeadquartersBala Cynwyd, Pennsylvania, United States
SectorBiotechnology
Websitelarimartx.com
Analyst Ratings
Based on 4 analysts giving stock ratings to LRMR in the past 3 months
Strong Buy
Buy
4
Hold
0
Sell
0
12 month forecast
Based on 4 Wall Street analysts offering 12 month price targets for LRMR in the last 3 months.
Highest
Current $3.63
$25.00 (+588.71%)
Average
$15.33 (+322.31%)
Lowest
$9.00 (+147.93%)
Analyst
Recommendation
Action
Price Target
Projected
Date
Tessa Romero
J.P. Morgan
Buy
Initiated
$9.00
+147.9%
05/27/2026
Myles Minter
William Blair
Buy
Reiterated
-
-
05/18/2026
Laura Chico
Wedbush
Buy
Maintained
$12.00
+230.6%
05/18/2026
Francois Brisebois
LifeSci Capital
Buy
Reiterated
$25.00
+588.7%
05/16/2026
Samantha Semenkow
Citi
Buy
Reiterated
$14.00
+285.7%
03/20/2026
Catherine Novack
JonesTrading
Buy
Maintained
$13.00
+258.1%
02/24/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
23.27M
44.83M
59.17M
24.93M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
4.52M
4.67M
4.84M
6.19M
Operating expense
27.79M
49.50M
64.02M
31.12M
Total operating expenses
27.79M
49.50M
64.02M
31.12M
Operating income
-27.79M
-49.50M
-64.02M
-31.12M
Other non operating income
1.61M
1.79M
1.52M
1.50M
EBT including unusual items
-26.18M
-47.71M
-62.50M
-29.61M
EBT excluding unusual items
-26.18M
-47.71M
-62.50M
-29.61M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-26.18M
-47.71M
-62.50M
-29.61M
Net profit margin
-
-
-
-
Earnings per share
-0.41
-0.61
-0.73
-0.31
Interest and investment income
-
-
-
-
Interest expense
-
-
-
-
Net interest expenses
-
-
-
-
Depreciation and amortization charges
-
-
-
-
EBITDA
-27.70M
-49.41M
-63.93M
-31.05M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer